Literature DB >> 3035016

Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.

J H Sisson, S M Prescott, T M McIntyre, G A Zimmerman.   

Abstract

Platelet-activating factor (PAF) is a phospholipid mediator of inflammation that is synthesized by several human cell types including polymorphonuclear leukocytes (PMN). We examined the synthesis and release of PAF by stimulated human PMN under several conditions, assayed by the incorporation of [3H]acetate into PAF and by bioassay. PAF synthesis was induced by calcium ionophore A23187 (IoA), opsonized zymosan (OpsZ), and N-formyl-methionyl-leucyl-phenylalanine (FMLP) with the relative order of potency IoA much greater than OpsZ greater than FMLP. A variety of other agonists, including phorbol myristate acetate, an activator of protein kinase C and of PMN functional responses, did not stimulate PAF synthesis. PAF synthesis by PMN in response to IoA, OpsZ, and FMLP was concentration- and time-dependent but release of the phospholipid was not: little PAF (1 to 10%) was released from PMN in suspension regardless of the total amount produced, the agonist, its concentration, the time of incubation, or the concentration of extracellular albumin. This was also the case with functionally altered neutrophils that had been "primed" with cytochalasin B or lipopolysaccharide or that had adhered to surfaces. PAF synthesis was tightly coupled with leukotriene B4 production by adherent PMN as well as by neutrophils in suspension, supporting the hypothesis that the two lipid autacoids may be derived from a common precursor. However, PAF synthesis could be dissociated from aggregation and surface adhesion, indicating that it is not absolutely required for these responses of activated PMN. The total amount of PAF that accumulated, but not the percentage that was released, was altered in adherent PMN compared to cells in suspension. These experiments demonstrate that PAF production and its subsequent processing by human neutrophils are highly regulated events. PAF synthesis is associated with PMN activation, but it is not a requisite for early adhesive responses of neutrophils. Because little of the PAF produced by stimulated PMN is released from the cells, it appears that PAF has an intracellular role in PMN function and/or that it may have novel intercellular effects that do not require release into the fluid phase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035016

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits.

Authors:  S Chakrabarty; D S Fluck; N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig.

Authors:  N A Flores; D J Sheridan
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 3.  Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance.

Authors:  J P Doucet; S P Squinto; N G Bazan
Journal:  Mol Neurobiol       Date:  1990 Spring-Summer       Impact factor: 5.590

4.  Effect of Staphylococcus aureus delta-toxin on human granulocyte functions and platelet-activating-factor metabolism.

Authors:  S Kasimir; W Schönfeld; J E Alouf; W König
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

Review 5.  Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system.

Authors:  N G Bazan; S P Squinto; P Braquet; T Panetta; V L Marcheselli
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

6.  Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes.

Authors:  A G Stewart; T Harris
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.

Authors:  N M Ruis; J K Rose; F H Valone
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

8.  IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates.

Authors:  P Hernando; J Egido; R de Nicolas; E Gonzalez
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

9.  Inflammatory roles of P-selectin.

Authors:  D E Lorant; M K Topham; R E Whatley; R P McEver; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Platelet-activating factor (PAF) stimulates the PAF-synthesizing enzyme acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase and PAF synthesis in neutrophils.

Authors:  T W Doebber; M S Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.